Abbvie Inc’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $207.32 on 10/31/24 and a low of $137.05 for the same time frame on 11/20/23.
52-week price history of ABBV Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Abbvie Inc’s current trading price is -19.80% away from its 52-week high, while its distance from the 52-week low is 21.33%. The stock’s price range during the 52-week period has remained between $137.05 and $207.32. In the Healthcare sector, the company’s shares saw a trading volume of around 8.1 million for the day, which was evidently higher than the average daily volume of 5.28 million over the past three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Market Capitalization and Financial Performance: An In-Depth Look
Abbvie Inc (ABBV) has experienced a quarterly decline of -15.23% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 285.80B and boasts a workforce of 50000 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 187.74, with a change in price of -2.71. Similarly, Abbvie Inc recorded 5,432,483 in trading volume during the last 100 days, posting a change of -1.60%.
Examining ABBV’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for ABBV stands at 11.78. Similarly, the long-term debt-to-equity ratio is also 9.70.
ABBV Stock Stochastic Average
As of today, Abbvie Inc’s raw stochastic average for the last 50 days stands at 3.66%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 3.66%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 2.33% and 1.87%, respectively.
ABBV Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The metric has seen a significant gain of 7.30% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 1.05%. Over the past 30 days, the price of ABBV has leaped by -11.96%. And in the last five days, it has fallen by -4.67%.
